{
    "title": "Cytokinetics sinks on abandoning ALS drug after failed trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5103897/Cytokinetics-abandons-ALS-drug-failed-trial.html",
    "date": "2017-11-21",
    "keywords": [
        "drug",
        "tirasemtiv",
        "ck2127107",
        "divya",
        "grover",
        "percent",
        "drugmaker",
        "function",
        "trial",
        "condition",
        "placebo",
        "profile",
        "dizziness",
        "analyst",
        "muscle",
        "blum",
        "tuesday",
        "disorder",
        "lung",
        "sclerosis",
        "disease",
        "nerve",
        "brain",
        "cord",
        "disability",
        "failure",
        "physicist",
        "stephen",
        "attention",
        "ice",
        "bucket",
        "challenge",
        "water",
        "research",
        "difference",
        "vital",
        "capacity",
        "volume",
        "air",
        "force",
        "latestage",
        "side",
        "tolerability",
        "dropoutrate",
        "followon",
        "compound",
        "bloodbrain",
        "barrier",
        "troponin",
        "activator",
        "mechanism",
        "secondgeneration",
        "chance",
        "jaffray",
        "executive",
        "robert",
        "company",
        "collaboration",
        "inc",
        "statement",
        "mitsubishi",
        "approval",
        "afternoon",
        "trading",
        "year",
        "low",
        "reporting",
        "bengaluru",
        "editing",
        "dsouza",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}